LIST OF APPROVED DRUG FROM 01-01-2012 to Till Date
|
Sl
No
|
Name of Drug
|
Indication
|
Date of issue
|
|
1.
|
Etravirine Tablet 100mg
|
In combination with other
antiretroviral agents for the treatment of human immunodeficiency virus type
1 (HIV-1) infection in antiretroviral treatment-experienced adult patients
who have evidence of viral replication and HIV-1 strains resistant to an
NNRTI and other antiretroviral agents.
It should be used only in situations where other treatments have
failed or cannot be used because of side effects.
|
26.04.12
|
|
2.
|
Blonanserin Tablet 2mg/4mg/8mg
|
For the treatment of Schizophrenia in
adult patients when first line treatment is ineffective.
|
24.04.12
|
|
3.
|
Etravirine Tablet 100mg
|
In combination with other
antiretroviral agents for the treatment of human immunodeficiency virus type
1 (HIV-1) infection in antiretroviral treatment-experienced adult patients
who have evidence of viral replication and HIV-1 strains resistant to an
NNRTI and other antiretroviral agents.
It should be used only in situations where other treatments have
failed or cannot be used because of side effects.
|
26.04.12
|
|
4.
|
Mucotrol Concentrated Oral Gel Wafer.
|
For the management of pain and relief
of pain, by adhering to the mucosal surface of the mouth, soothing oral
lesions of various etiologies, including oral mucositis/stomatitis (may be
caused by chemotherapy or radiotherapy).
Irritation due to oral surgery and traumatic ulcers caused by braces
or ill fitting dentures of diseases and for diffuse apthous ulcers.
|
07.03.12
|
|
5.
|
Ulinastatin for Injection 50000 IU /
100000 IU
|
For the treatment of severe sepsis.
|
03.04.12
|
|
6.
|
Sterile Solution for Peritoneal Dialysis Each
1000 ml contains: Calcium chloride
dihydrate 0.184 g/l + Glycine 0.51 g/l + L- Alanine 0.951 g/l + L- Arginine
1.071 g/l + L- Isoleucine 0.85 g/l + L- Histidine 0.714 g/l + L- Leucine 1.02
g/l + L- Lysine (as Hcl) 0.955 g/l + L-Methionine 0.85 g/l + L- Phenylalanine
0.57 g/l + L-Proline 0.595 g/l + L- Serine 0.51 g/l + L- Threonine 0.646 g/l
+ L-Tryptophan 0.27 g/l + L-Tyrosine 0.3 g/l + L-Valine 1.393 g/l + Magnesium
chloride hexahydrate 0.051 g/l + Sodium chloride 5.38 g/l + Sodium lactate
4.48 g/l
|
As Nutritional supplements for malnourished renal failure
patients (Albumin concentration lower than 35 g/litre) being maintained on
peritoneal dialysis.
|
18.04.12
|
|
7.
|
Cephalexin
IP (as monohydrate) 200mg + Kanamycin IP (as monosulphate) 100,000 IU
Suspension per 10 gm Intramammary Suspension
|
For the
treatment of clinical mastitis in lactating dairy cows for bacteria
susceptible to the combination of cephalexin and kanamycin such as
Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis and
Escheria coli.
|
07.03.12
|
|
8.
|
Plerixafor
Injection 20mg/ml
|
In combination
with Granulocyte Colony Stimulating Factor (G-CSF) to enhance mobilisation
of hematopoietic stem cells to the
peripheral blood for collection and subsequent autologous hematopoeitic stem
cells transplantation in patients with non-Hodgkin’s lymphoma and multiple
myeloma whose cells mobilise poorly.
|
31.01.12
|
|
9.
|
Eribulin mesylate
solution for injection 0.88mg / 2ml vial
|
For the treatment
of patients with locally advanced or metastatic breast cancer who have
progressed after at least two chemotherapeutic regimens for advanced disease.
Prior therapy should have included an anthracycline and a taxane unless
patients were not suitable for these treatments.
|
27.01.12
|
|
10.
|
Linagliptin film
coated Tablet 5mg
|
As an adjunct to
diet and exercise to improve glycemic control in adults with type 2 diabetes
mellitus.
Important limitations of use:
1. Should not be used in patients with type 1 diabetes or for the treatment
of diabetic ketoacidosis.
2. Has not been
studied in combination with insulin.
|
23.01.12
|
|
11.
|
Degarelix for
Injection 80mg / 120mg per vial
|
For the treatment
of adult patients with advanced hormone dependent prostate cancer.
|
19.01.12
|
|
12.
|
Diclofenac Sodium IP (Enteric coated granules) 50mg +
Eperisone Hcl IP (Tablet) 50mg Hard Gelatin Capsules. (New Dosage Form)
|
For the treatment of Patients with acute musculoskeletal
spasm associated with low back pain
|
06.01.12
|
|
13.
|
Aceclofenac IP (Sustained released pellets) 200mg/200mg
+ Thiocolchicoside IP (Sustained released pellets) 8mg/16mg Capsules. (New Dosage Form)
|
For the treatment of acute inflammation conditions
associated with spasm in adults only
|
04.01.12
|
|
14.
|
Budesonide IP 1mg/0.5mg + Formoterol Fumarate Dihydrate
IP eq to Formoterol Fumarate 20mcg/20mcg Respirator suspension. (Additional
Indication)
|
In the regular treatment of patients with moderate to severe
Chronic Obstructive Pulmonary Disease (COPD) with frequent symptoms and a
history of exacerbations.
|
04.01.12
|
|
15.
|
Ornidazole IP 1 % w/w + Povidone Iodine IP (0.5% w/w
available Iodine) 5% w/w Ointment
|
For the prevention and treatment of surgical wound infections
in adult patients undergoing surgery
|
03.01.12
|
Reference: http://cdsco.nic.in/listofdrugapprovedmain.html
No comments:
Post a Comment